The GLP is committed to full transparency. Download and review our 2019 Annual Report

Viewpoint: Trump’s fetal-tissue research ban ‘ignores and defies the facts’

| | June 11, 2019
de f e a b d e dcf c e vpc sotu abortion thumb
Image: USA Today
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The Trump administration is halting fetal tissue research by government scientists and placing new restrictions on how the National Institutes of Health issues grants to academic researchers. The move is meant to appease the president’s anti-choice political base, but the measures are a serious blow to medical science.

The sticking point for the president has to do with the fact that fetal tissue is collected from abortions.

Fetal tissue, with its unique biological properties, offers important insights into vaccines, human growth and development, regenerative medicine, eye disorders, and many other lines of research.

“There is no good reason—even for someone opposed to abortion—to oppose this research.”

Related article:  Trump administration halts US funding for fetal tissue research, threatening work on AIDS, cancer and other diseases

David Magnus, a professor at the Stanford Center for Biomedical Ethics, said this is a major shift away from policy that had been adopted by previous Republican and Democratic administrations. He’s now worried that new measures will result in the loss of several important avenues of research, including studies on HIV, neurological disease, and vaccine development.

“Good policy begins with good facts. This policy ignores and defies the facts.” [said bioethicist R. Alta Charo.]

Read full, original post: Trump’s Misguided Ban on Federal Fetal-Tissue Research Can Only Hurt Science

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend